Repherans noktası

Şubat 2022 yayın taraması

Tedaviye özel yayınlar

Sildenafil

PAH

1. Shi Q et al. Sildenafil for adult Asian patients with pulmonary arterial hypertension: A systematic review and meta-analysis. Ann Palliat Med. 2022;11(1):339-51. PMID:35144425.

Riociguat

KTEPH

2. Barnikel M et al.Riociguat in patients with CTEPH and advanced age and/or comorbidities. J Clin Med. 2022;11(4). PMID:35207354.

Genel PH tedavisi

Akciğer hastalıkları ve/veya hipoksiye bağlı PH (Grup 3)

3. Arif R et al. Treatment of pulmonary hypertension associated with COPD: A systematic review. ERJ Open Res. 2022;8(1). PMID:35198628.

Kombinasyon tedavisi

Pediatrik PAH

4. Steffes LC, Austin ED. Upfront combination therapy: Growing the case to get ahead of pediatric pulmonary arterial hypertension. (Editorial) Ann Am Thorac Soc. 2022;19(2):163-5. PMID:35103566.

Non-farmakolojik

PH

5. Carta AF et al. The impact of breathing hypoxic gas and oxygen on pulmonary hemodynamics in patients with pulmonary hypertension. Front Med (Lausanne). 2022;9:791423. PMID:35223898.

6. Zheng Z et al. A meta-analysis of the efficacy of pulmonary artery denervation in the treatment of pulmonary hypertension. (Review) Heart Lung. 2022 [Epub]. PMID:35144042.

KTEPH

7. Akaslan D et al. Change in pulmonary arterial compliance and pulmonary pulsatile stress after balloon pulmonary angioplasty. Anatol J Cardiol. 2022;26(1):43-8. PMID:35191385.

Etiyolojiye özel yayınlar

Pulmoner hipertansiyon

Genel PH

8. Abu T et al. Preoperative evaluation of pulmonary hypertension in lung transplant candidates: Echocardiography versus right heart catheterization. BMC Cardiovasc Disord. 2022;22(1):53. PMID:35172724.

9. Albani Set al. Echocardiographic biventricular coupling index to predict pre-capillary pulmonary hypertension. J Am Soc Echocardiogr. 2022 [Epub]. PMID:35158052.

10. Alıcı G, Genç Ö. Prevalence and etiologies of pulmonary hypertension at Somalia-Turkey Training and Research Hospital in Mogadishu. Pan Afr Med J. 2021;40:215. PMID:35136478.

11. Barbagelata L et al. Prognostic role of cardiopulmonary exercise testing in pulmonary hypertension: A systematic review and meta-analysis. Adv Respir Med. 2022 [Epub]. PMID:35199845.

12. Berlier C et al. Influence of upright versus supine position on resting and exercise hemodynamics in patients assessed for pulmonary hypertension. J Am Heart Assoc. 2022;11(4):e023839. PMID:35156392.

13. Fortmeier V et al. Solving the pulmonary hypertension paradox in patients with severe tricuspid regurgitation by employing artificial intelligence. JACC Cardiovasc Interv. 2022;15(4):381-94. PMID:35210045.

14. Karam N, Hausleiter J. Can artificial intelligence solve pulmonary hypertension paradox in severe tricuspid regurgitation? (Editorial) JACC Cardiovasc Interv. 2022;15(4):395-6. PMID:35210046.

15. Kräuter C et al. Automated vortical blood flow-based estimation of mean pulmonary arterial pressure from 4D flow MRI. Magn Reson Imaging. 2022 [Epub]. PMID:35189283.

16. Pu S et al. The association of body mass index with the risk of pulmonary hypertension in adults: A systematic review and meta-analysis of observational studies. Front Med (Lausanne). 2021;8:680223. PMID:35145969.

17. Robertson L et al. The prognostic ability of cardiac output determined by inert gas rebreathing technique in pulmonary hypertension. Chron Respir Dis. 2022;19:14799731221078473. PMID:35184583.

18. Sørensen HT et al. Cancer risk in pulmonary hypertension patients. Clin Epidemiol. 2022;14:173-7. PMID:35210864.

19. Vos JL et al. Right atrial and ventricular strain detects subclinical changes in right ventricular function in precapillary pulmonary hypertension. Int J Cardiovasc Imaging. 2022 [Epub]. PMID:35190941.

20. Walter R et al. Hemodynamically unloading the distal pulmonary circulation in pulmonary hypertension: A modeling study. J Biomech Eng. 2022;144(2). PMID:34251418.

21. Christou H, Khalil RA. Mechanisms of pulmonary vascular dysfunction in pulmonary hypertension and implications for novel therapies. (Review) Am J Physiol Heart Circ Physiol. 2022 [Epub]. PMID:35213243.

22. Colon Hidalgo D et al. Metabolism, mitochondrial dysfunction, and redox homeostasis in pulmonary hypertension. (Review) Antioxidants (Basel). 2022;11(2). PMID:35204311.

23. Ota H et al. Clinical application of 4D flow MR imaging to pulmonary hypertension. (Review) Magn Reson Med Sci. 2022;21(2):309-18. PMID:35185084.

24. Vrigkou E et al. The role of thyroid disorders, obesity, diabetes mellitus and estrogen exposure as potential modifiers for pulmonary hypertension. (Review) J Clin Med. 2022;11(4). PMID:35207198.

İlaç ve toksinlere bağlı PH

25. Tamura Y, Tamura Y. Dasatinib-induced pulmonary hypertension. Intern Med. 2022 [Epub]. PMID:35110497.

Pediatrik PH

26. Maloney MA et al.Prevalence of pulmonary hypertension on echocardiogram in children with severe obstructive sleep apnea. J Clin Sleep Med. 2022 [Epub]. PMID:35212261.

27. Stein ML et al. Anesthesia in children with pulmonary hypertension: Clinically significant serious adverse events associated with cardiac catheterization and noncardiac procedures. J Cardiothorac Vasc Anesth. 2022 [Epub]. PMID:35181233.

Pulmoner arteriyel hipertansiyon (Grup 1)

Genel PAH

28. Cipolletta S, Ravasio G, Bussotti M. Sexual and reproductive health in women with pulmonary hypertension: A qualitative study. Arch Sex Behav. 2022 [Epub]. PMID:35165801.

29. Fuge J et al. Impact of pulmonary arterial hypertension on employment, work productivity, and quality of life - Results of a cross-sectional multi-center study. Front Psychiatry. 2021;12:781532. PMID:35211036.

30. Olsson KM et al. Refined risk stratification in pulmonary arterial hypertension and timing of lung transplantation. Eur Respir J. 2022 [Epub]. PMID:35144993.

31. Park DH et al. Childhood trauma in patients with PAH-prevalence, impact on QoL, and mental health - A preliminary report. Front Psychiatry. 2022;13:812862. PMID:35222119.

32. Wang P et al. Additional use of prostacyclin analogs in patients with pulmonary arterial hypertension: A meta-analysis. Front Pharmacol. 2022;13:817119. PMID:35222031.

33. Yee DC et al. Sexual health-related quality of life in women with pulmonary arterial hypertension: Compensating for loss. Ann Am Thorac Soc. 2022 [Epub]. PMID:35119972.

34. Zeren M et al. Prevalence of musculoskeletal pain and its impact on quality of life and functional exercise capacity in patients with pulmonary arterial hypertension. Respir Med. 2022;193:106759. PMID:35134632

35. Zhang J et al. Anxiety and depression in patients with pulmonary arterial hypertension in northwest China: A cross-sectional study. Front Psychiatry. 2021;12:758120. PMID:35185632.

36. Freed BH. REPAIRing what we can’t see: The need for imaging endpoints in PAH clinical trials. (Editorial) JACC Cardiovasc Imaging. 2022;15(2):254-6. PMID:34801460.

37. Liang S et al. Mitochondrial metabolism, redox, and calcium homeostasis in pulmonary arterial hypertension. (Review) Biomedicines. 2022;10(2). PMID:35203550.

38. Oh S et al. Stem cell and exosome therapy in pulmonary hypertension. (Review) Korean Circ J. 2022;52(2):110-22. PMID:35128849.

39. Welch CL, Chung WK. Channelopathy genes in pulmonary arterial hypertension. (Review) Biomolecules. 2022;12(2). PMID:35204766.

40. Yoo HHB, Marin FL. Treating inflammation associated with pulmonary hypertension: An overview of the literature. (Review) Int J Gen Med. 2022;15:1075-83. PMID:35140509.

İdiyopatik PAH

41. Yan L et al. The prognostic impact of serum uric acid on disease severity and 5-year mortality in patients with idiopathic pulmonary artery hypertension. Front Med (Lausanne). 2022;9:805415. PMID:35155496.

42. Yang X et al. Identification of crucial hub genes and differential T Cell infiltration in idiopathic pulmonary arterial hypertension using bioinformatics strategies. Front Mol Biosci. 2022;9:800888. PMID:35127829.

İlişkili PAH

43. Baroutidou A et al. Haemoptysis in pulmonary arterial hypertension associated with congenital heart disease: Insights on pathophysiology, diagnosis and management. J Clin Med. 2022;11(3). PMID:35160084.

44. Colalillo A et al. In systemic sclerosis TAPSE/sPAP ratio is correlated with ventilatory efficiency and exercise capacity assessed by CPET. Clin Exp Med. 2022 [Epub]. PMID:35150361.

45. Kolstad KD et al. Cytokine signatures differentiate systemic sclerosis patients at high versus low risk for pulmonary arterial hypertension. Arthritis Res Ther. 2022;24(1):39. PMID:35139913.

46. Lázaro SM et al. Management and prognosis of HIV-associated pulmonary arterial hypertension: 20 years of evidence from the REHAP registry. J Intern Med. 2022 [Epub]. PMID:35184348.

47. Mehra P et al. Endothelin-1 gene and endothelin receptor A gene polymorphisms in severe pulmonary hypertension associated with rheumatic mitral valve disease. Arch Med Sci. 2022;18(1):260-6. PMID:35154546.

48. DuBrock HM, Del Valle KT, Krowka MJ. Mending the MELD: An in-depth review of the past, present, and future portopulmonary hypertension MELD exception. (Review) Liver Transpl. 2022 [Epub]. PMID:35106916.

49. Kolaitis NA et al. Human immune deficiency virus-associated pulmonary arterial hypertension: A report from the pulmonary hypertension association registry. (Review) Am J Respir Crit Care Med. 2022 [Epub]. PMID:35180043.

Pediatrik PAH

50. Huang Y et al. Expression and clinical significance of circular RNA hsa_circ_0003416 in pediatric pulmonary arterial hypertension associated with congenital heart disease. J Clin Lab Anal. 2022 [Epub]. PMID:35165927.

Sol kalp hastalığına bağlı PH (Grup 2)

51. Karadavut S, Cetin M. A novel factor in determining the risk of ischemic cerebrovascular events in patients with atrial fibrillation: Pulmonary hypertension. J Stroke Cerebrovasc Dis. 2022 [Epub]. PMID:35182946.

52. Quan R et al. Risk prediction in pulmonary hypertension due to chronic heart failure: Incremental prognostic value of pulmonary hemodynamics. BMC Cardiovasc Disord. 2022;22(1):56. PMID:35172722.

53. Tanaka S et al. Stabilization of RyR2 maintains right ventricular function, reduces the development of ventricular arrhythmias, and improves prognosis in pulmonary hypertension. Heart Rhythm. 2022 [Epub]. PMID:35134547.

54. Yang JH et al. Peripheral venous pressure-assisted exercise stress echocardiography in the evaluation of pulmonary hypertension during exercise in patients with suspected heart failure with preserved ejection fraction. Circ Heart Fail. 2022 [Epub]. PMID:35189688.

55. Lunardi M et al. Acute and chronic exercise training in patients with class II pulmonary hypertension: Effects on haemodynamics and symptoms. (Review) ESC Heart Fail. 2022 [Epub]. PMID:35132779.

Akciğer hastalıkları ve/veya hipoksiye bağlı PH (Grup 3)

56. Aguirre-Franco C et al. Prevalence of pulmonary hypertension in COPD patients living at high altitude. Pulmonology. 2022 [Epub]. PMID:35151623.

57. Rahaghi FF et al. Screening strategies for pulmonary hypertension in patients with interstitial lung disease: A multidisciplinary Delphi study. Chest. 2022 [Epub]. PMID:35176276.

58. Yang D et al. Correlation between hs-CRP, IL-6, IL-10, ET-1, and chronic obstructive pulmonary disease combined with pulmonary hypertension. J Healthc Eng. 2022;2022:3247807. PMID:35186226.

KTEPH ve diğer pulmoner arter obstrüksiyonları (Grup 4)

59. Blanquez-Nadal M et al. Neural respiratory drive in chronic thromboembolic pulmonary hypertension: Effect of balloon pulmonary angioplasty. Respir Physiol Neurobiol. 2022;299:103857. PMID:35121103.

60. Clements W et al. Chronic Thromboembolic Pulmonary Hypertension (CTEPH) and massive hemoptysis: The rationale for bronchial artery embolization. Respir Med. 2022 [Epub]. PMID:35232634.

61. Dzikowska-Diduch O et al. A novel Doppler TRPG/AcT index improves echocardiographic diagnosis of pulmonary hypertension after pulmonary embolism. J Clin Med. 2022;11(4). PMID:35207345.

62. Eberhard M et al. Dual-energy CT pulmonary angiography for the assessment of surgical accessibility in patients with chronic thromboembolic pulmonary hypertension. Diagnostics (Basel). 2022;12(2). PMID:35204319.

63. Kroeger JR et al. Detection of patients with chronic thromboembolic pulmonary hypertension by volumetric iodine quantification in the lung - a case control study. Quant Imaging Med Surg. 2022;12(2):1121-9. PMID:35111609.

64. Sławek-Szmyt S et al. Association of electrocardiographic signs of right ventricular hypertrophy and clot localization in chronic thromboembolic pulmonary hypertension. J Clin Med. 2022;11(3). PMID:35160075.

65. Wang L et al. Ventilation/perfusion imaging predicts response to balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension. Ann Nucl Med. 2022 [Epub]. PMID:35194769.

66. Zhang L et al. Right ventricular end-systolic remodeling index on cardiac magnetic resonance imaging: Comparison with other functional markers in patients with chronic thromboembolic pulmonary hypertension. Quant Imaging Med Surg. 2022;12(2):894-905. PMID:35111592.

67. Puebla-Aldama D et al. Review of functional status and hemodynamic parameters in patients diagnosed with Chronic Thromboembolic Pulmonary Hypertension (CTEPH) with and without Antiphospholipid Syndrome (APLS). (Review) Curr Probl Cardiol. 2022 [Epub]. PMID:35192873.

68. Ruaro B et al. Chronic thromboembolic pulmonary hypertension: An update. (Review) Diagnostics (Basel). 2022;12(2). PMID:35204326.

69. Tzoumas A et al. Advances in treatment of chronic thromboembolic pulmonary hypertension. Thromb Res. (Review) 2022 [Epub]. PMID:35217332.

Belirsiz ve/veya çok faktörlü mekanizmalara sahip PH (Grup 5)

70. Huitema MP et al. Echocardiographic estimate of pulmonary artery pressure in sarcoidosis patients - real world data from a multi-national study. Sarcoidosis Vasc Diffuse Lung Dis. 2022;38(4):e2021032. PMID:35115744.

71. Savale L et al. WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension. (Review) Eur Respir Rev. 2022;31(163). PMID:35140103.

SSc-DU

72. Colic J et al. Impaired fibrinolysis is linked with digital vasculopathy and onset of new digital ulcers in systemic sclerosis. J Rheumatol. 2022 [Epub]. PMID:35169064.

Hazırlama tarihi: Mart 2022

CP-309968